Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500393 · ClinicalTrials.gov registry record · NA
A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03500393 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT03500393, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a pilot randomized controlled trial (RCT) evaluating the feasibility and potential effectiveness of a remotely supervised exercise program (REM) in promoting adherence to an exercise prescription before and during chemoradiation.
Interventions
- BEHAVIORAL Remotely Supervised Exercise (REM)
- BEHAVIORAL Unsupervised Exercise (UNSUP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-06-22 |
| Est. Completion | 2021-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500393
The ClinicalTrials.gov registry entry for NCT03500393 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Remotely Supervised Exercise (REM) is the first listed.
NCT03500393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500393 about?
NCT03500393 is a clinical study titled "A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)". The purpose of this study is to conduct a pilot randomized controlled trial (RCT) evaluating the feasibility and potential effectiveness of a remotely supervised exercise program (REM) in promoting adherence to an exercise prescription before and during chemoradiation.
What is the current status of trial NCT03500393?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-06-22. Estimated completion is 2021-01-23.
What interventions are being tested in trial NCT03500393?
The interventions under investigation include: Remotely Supervised Exercise (REM) (BEHAVIORAL), Unsupervised Exercise (UNSUP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03500393?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.